Want to join the conversation?
$PFE will pay $550MM to AstraZeneca upon deal close and will make a $175MM deferred payment in Jan. 2019. AstraZeneca is also eligible to receive up to $250MM in milestone payments, up to $600MM in sales-related payments, and tiered royalties on sales of Zavicefta and ATM-AVI in some markets. Deal is not expected to impact $PFE's 2016 guidance.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?